As of Thursday, February 26, OraSure Technologies, Inc.’s OSUR share price has surged by 6.96%, which has investors questioning if this is right time to sell.

OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended ...

Add Yahoo as a preferred source to see more of our stories on Google. Health Canada has approved the OraQuick HIV self-test, making it the country's first oral self-test for the virus that causes AIDS ...

Add Yahoo as a preferred source to see more of our stories on Google. Dr. Sean Rourke, a Toronto-based clinical neuropsychologist and scientist at St. Michael's Hospital, holds up the box of new oral ...

Loading external pages may require significantly more data usage than loading CBC Lite story pages. People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's ...

BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today ...

Add Yahoo as a preferred source to see more of our stories on Google. An oral, at-home HIV test that delivers results in as little as 20 minutes and has been used in the U.S. for well over a decade is ...

TORONTO - An oral, at-home HIV test that delivers results in as little as 20 minutes and has been used in the U.S. for well over a decade is finally coming to Canada. OraSure Technologies announced ...

An at-home, self-testing HIV kit that promises results in 20 minutes has been approved for use in Canada. On Tuesday, OraSure Technologies announced that its OraQuick HIV self-test has received its ...

BETHLEHEM, Pa. - OraSure Technologies, Inc. (NASDAQ:OSUR) announced Tuesday that its OraQuick HIV Self-Test has received a license from Health Canada, making it the first oral HIV self-test approved ...